LadyAnge
It has been my, perhaps fantasy assumption, that RCPIQ's Chapter 7 bankruptcy application was a strategy to stop the hemorrhaging of shares resulting from a failed loan arrangement. That fantasy imagines that RCPIQ had made an arrangement with the lender under which it would become a "shell" into which MYMD Pharmaceutical would reverse merge. It would then issue MYMD shares for the shares of RCPIQ held by the lender, thereby converting the existing debt into a stock position in MYMD Pharma.
My preferred arrangement would be for MYMD to authorize 17.04 million shares, and issue to RCPIQ shareholders 1 share of its stock for each 10 shares of RCPIQ stock.